Business & Finance
ICF awarded USD120m USAID infectious disease detection and surveillance project
31 July 2018 -

Consulting services company ICF (NASDAQ:ICFI) reported on Monday the receipt of a new task order to support the US Agency for International Development (USAID) to provide infectious disease detection and surveillance support to affected lower and middle income countries worldwide.

The task order was awarded by the Bureau for Global Health, Office of Infectious Disease under the US General Services Administration's OASIS (One Acquisition Solution for Integrated Services) indefinite delivery, indefinite quantity contract.

Under a ceiling value of USD120m and a term of five years including one base year and four option years, ICF will provide direct implementation support services and capacity building assistance to countries to develop or improve their national diagnostic networks, laboratory systems and surveillance mechanisms so they are better able to detect and monitor the ever-growing number of emerging and re-emerging infectious diseases, including Ebola and multidrug-resistant tuberculosis.

As part of this contract, ICF will strengthen its partnership with USAID in helping it meet its vision of providing high-quality, specific technical assistance and support to countries to enable them to rapidly detect new and emerging infectious diseases and pathogens.

Additionally, ICF will support USAID's partnership within the US government to advance the Global Health Security Agenda, a worldwide effort to help build countries' capacity to help create a world safe and secure from infectious disease threats and elevate global health security as a national and global priority.

Login
Username:

Password: